More News

Clarifi Imaging System for Microvascular Assessment Receives CE Mark An Important Milestone for Modulim

The CE Mark certification allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

The Ultimate End of Life Planning Checklist

With Pillar, you can get ahead of that by proactively planning. Take things one day at a time so you can be less stressed in the future and focus more on the real things that matter – the person you love.

Activ Surgical Joins Qualcomm Smart Cities Accelerator Program

June 30, 2020

Activ Surgical, a digital surgery pioneer, today announced that it has joined the Qualcomm® Smart Cities Accelerator Program and is collaborating with Innominds on the development of next-generation surgical sensing capabilities that will usher in a new era of visibility and insights for surgeons around the world.

ActivSurgical notes as part of the Qualcomm® Advantage Network, the Qualcomm Smart Cities Accelerator Program is designed to connect cities, municipalities, government agencies and enterprises with an ecosystem of providers to help deliver greater efficiencies, cost savings, safety and sustainability. With proven expertise in commercially deployed solutions, program members include hardware and software providers, cloud solution providers, system integrators and design and manufacturing companies, as well as those offering end-to-end smart city solutions.

“We are humbled and honored to join the Qualcomm Smart Cities Accelerator Program, particularly as we begin to ramp up deployments of our surgical intelligence platform into healthcare systems across the U.S. this year,” said Todd Usen, CEO, Activ Surgical. “We share Qualcomm Technologies’ vision to empower global access to best-in-class surgery, regardless of geography.”

Activ Surgical’s participation in the program and collaboration with Qualcomm Technologies will help increase opportunities for healthcare systems in the U.S. and in global markets to leverage its newly announced ActivEdge platform. ActivEdge is an AI and machine-learning (ML) hardware-agnostic platform that enables existing surgical systems to see in real-time what humans cannot currently see, including blood flow. Participation in the Qualcomm Smart Cities Accelerator Program will give Activ Surgical critical access to hardware- and software-enabled communication tools and 5G networks that will help bring these insights to every operating room around the world.

“Digital healthcare and telemedicine are extremely important elements of our smart, connected world, and will only continue to grow in importance,” said Sanjeet Pandit, senior director, business development and head of smart cities, Qualcomm Technologies, Inc. “We are happy to include Activ Surgical in the Qualcomm Smart Cities Accelerator Program to help grow this vital area.”

Activ Surgicals’ membership in the Qualcomm Smart Cities Accelerator Program also links it with Innominds, a specialist full-cycle product engineering services company. Activ Surgical and Innominds are currently working on the development of an AI-powered camera that can be used in digital surgeries, as well as a solution for big data ingestion into the cloud. The collaboration is expected to drive transformation initiatives in data-driven, intelligent surgery by bringing together both companies’ expertise across ML, 5G, big-data analytics and advanced visualization solutions for surgery.

“We are excited to collaborate with Innominds as part of the Qualcomm Smart Cities Accelerator Program,” said Tom Calef, CTO, Activ Surgical. “Our work will ensure that surgeons everywhere will have greater access to cutting-edge technologies that enable them to make better-informed decisions and ultimately make a greater impact on reducing the number of avoidable surgical errors that occur each day.”

“Working with Activ Surgical enables Innominds to bring together leading-edge device engineering, breakthrough software product engineering, cloud applications and AI-driven data engineering to power digital surgeries of the future,” said Anil Katakam, Chief Operating Officer, Innominds. “This collaboration will ensure that we stay at the forefront of developing AI-powered, connected camera/imaging solutions that are simpler, smarter and more cost-effective. This is a firm step in our endeavor to power the digital next initiatives of global companies that we work with.”

Latest Posts

TRIMEDX Acquires Centurion Service Group a Full-Service Surplus Medical Equipment Management Company

TRIMEDX’s acquisition of Centurion Service Group will enhance TRIMEDX’s clinical asset management and informatics solutions.

Clarifi Imaging System for Microvascular Assessment Receives CE Mark An Important Milestone for Modulim

The CE Mark certification allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

Muvr Labs Is Acquired by Exactech

Orthopaedic surgeon Alexander Sah, MD, in Fremont, Calif. has seen the positive impact of Muvr technology on his practice. “Patients are attracted to the technology because they know our team is monitoring their progress; remarkably, this has caused my patients to take more ownership of their recovery,” he said.

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.